Lugar de publicación
- Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. 406(10500):235-260. 2025
- Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. 403(10440):2204-2256. 2024
- Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. 403(10440):1989-2956. 2024
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. 403(10440):2162-2203. 2024
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. 404(10459):1199-1226. 2024
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. 403(10440):2057-2099. 2024
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. 403(10440):2133-2161. 2024
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. 402(10397):203-234. 2023
- Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. 400(10369):2221-2248. 2022
- Diagnostic approaches for paediatric tuberculosis by use of di¿ erent specimen types, culture methods, and PCR: a prospective case-control study. 10:612-620. 2010
- Eficacy and Safety of an Oral Live Atenuated Human Rotavirus Vaccine Against Rotavirus Gastroenteritis During the First 2 Years of Life in Latin American Infants: a Randomised, Double-Bling, Placebo-Controlled Phase III Study. 371:1181-1189. 2008